Recombinant von Willebrand factor

被引：0
|
作者：
Schwarz, HP
Turecek, PL
Pichler, L
Mitterer, A
Mundt, W
Dorner, F
Roussi, J
Drouet, L
机构：
[1] HOP RAYMOND POINTCARE,GARCHES,FRANCE
[2] HOP LARIBOISIERE,F-75475 PARIS,FRANCE
来源：
THROMBOSIS AND HAEMOSTASIS | 1997年 / 78卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：571 / 576
页数：6
相关论文
共 50 条
  • [1] Evaluation of recombinant von Willebrand factor in a canine model of von Willebrand disease
    Schwarz, HP
    Dorner, F
    Mitterer, A
    Mundt, W
    Schlokat, U
    Pichler, L
    Turecek, PL
    [J]. HAEMOPHILIA, 1998, 4 : 53 - 62
  • [2] In vivo characterization of recombinant von Willebrand factor in dogs with von Willebrand disease
    Turecek, PL
    Gritsch, H
    Pichler, L
    Auer, W
    Fischer, B
    Mitterer, A
    Mundt, W
    Schlokat, U
    Dorner, F
    Erinkman, HJM
    vanMourik, JA
    Schwarz, HP
    [J]. BLOOD, 1997, 90 (09) : 3555 - 3567
  • [3] Pharmacokinetics of a Recombinant Von Willebrand Factor in Patients with Severe Von Willebrand Disease
    Ragni, Margaret V.
    Castaman, Giancarlo
    Gill, Joan Cox
    Kouides, Peter
    Chapman, Miranda
    Sytkowski, Arthur
    Obermann-Slupetzky, Ortrun
    Presch, Isabella
    Fritsch, Sandor
    Ewenstein, Bruce M.
    [J]. BLOOD, 2015, 126 (23)
  • [4] Recombinant von Willebrand factor: Preclinical development
    Plaimauer, B
    Schlokat, U
    Turecek, PL
    Mitterer, A
    Mundt, W
    Auer, W
    Pichler, L
    Gritsch, H
    Dorner, F
    Schwarz, HP
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2001, 27 (04): : 395 - 403
  • [5] Preclinical evaluation of recombinant von Willebrand factor in a canine model of von Willebrand disease
    Schwarz, HP
    Dorner, F
    Mitterer, A
    Mundt, W
    Schlokat, U
    Pichler, L
    Turecek, PL
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 1999, 111 (05) : 181 - 191
  • [6] In Vitro Assessment of von Willebrand Factor in Cryoprecipitate, Antihemophilic Factor/VWF Complex (Human), and Recombinant von Willebrand Factor
    Colling, Meaghan E.
    Friedman, Kenneth D.
    Dzik, Walter H.
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2019, 25
  • [7] Recombinant von Willebrand factor (vonicog alfa) in von Willebrand disease: a guide to its use
    Lyseng-Williamson K.A.
    [J]. Drugs & Therapy Perspectives, 2016, 32 (11) : 456 - 462
  • [8] Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand disease
    Gill, Joan C.
    Castaman, Giancarlo
    Windyga, Jerzy
    Kouides, Peter
    Ragni, Margaret
    Leebeek, Frank W. G.
    Obermann-Slupetzky, Ortrun
    Chapman, Miranda
    Fritsch, Sandor
    Pavlova, Borislava G.
    Presch, Isabella
    Ewenstein, Bruce
    [J]. BLOOD, 2015, 126 (17) : 2038 - 2046
  • [9] Recombinant von Willebrand factor: Potential therapeutic use
    Fischer, BE
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 1999, 8 (03) : 197 - 205
  • [10] Von Willebrand factor (Vonvendi®): the first recombinant product licensed for the treatment of von Willebrand disease
    Franchini, Massimo
    Mannucci, Pier Mannuccio
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2016, 9 (09) : 825 - 830
12345